Press

Bizkaia hosts BIOSPAIN 2026, turning the Basque Country into a European hub for biotechnology innovation and strategic autonomy

28/04/2026

Industrial biotechnology · International · BioSpain

• The Bilbao Exhibition Centre will host the next edition of BIOSPAIN from September 29 to October 1.
• Under the slogan “Bioinnovation that clicks,” the congress will feature a program focused on health, bioeconomy, and digitalization, with national and international experts, as well as keynote speakers such as Juan Bueren, who will discuss the sector’s major strategic and technological challenges.
• The congress will serve as a key platform for networking and generating business opportunities, with the participation of international investors. The final day will be dedicated to Talent Day, fostering connections between students, researchers, and companies.

AseBio

Green Innovation Forum brings together leading professionals and companies from the biotechnology and agri-food sectors in Salamanca for its sixth edition

21/04/2026

Climate change · Agrifood · Food & feed · Agriculture · Industrial biotechnology · Financing

• The event, organized by AseBio and the Salamanca City Council, was held this Tuesday at the Congress and Exhibition Center of the Tormes capital. It brought together 120 attendees from 75 organizations across five countries, as well as eight investment entities.
• The program has provided a global overview of the challenges and opportunities in food innovation, foodtech, and green biotechnology, with the participation of various stakeholders who analyzed how to drive the development and application of new solutions.
• It has also offered a space for generating new business and investment opportunities, thanks to its partnering platform, which enabled nearly one hundred bilateral meetings.

AseBio

MTBVAC moves toward its final stage: the vaccine candidate that could mark a turning point in the fight against tuberculosis

24/03/2026

Healthcare · Innovative drugs

• According to WHO and ECDC data, 161,569 cases were reported in 2024 across 51 of the 53 countries in the European region, equivalent to 17.2 cases per 100,000 inhabitants.
• One of the main challenges is the diagnosis gap: it is estimated that nearly one in five tuberculosis cases in Europe goes undetected.
• In this context, MTBVAC, a tuberculosis vaccine candidate under development, is in an advanced stage of clinical development, and its potential approval could represent a significant breakthrough in the fight against tuberculosis.
  
   

AseBio

Diana Morant, Minister for Science, Innovation and Universities: “Biotechnology is a strategic sector for protecting citizens”

10/03/2026

Healthcare · Agrifood · Industrial biotechnology · Financing

• The Spanish Bioindustry Association (AseBio) has organized a conference at the Ministry of Science that brought together leading institutional, political, and industry stakeholders to present a manifesto with 10 key measures to boost Spain’s biotechnology sector.
• “After a year of dialogue with the sector and institutional representatives, today we present a call to action: the time has come to join forces and position Spain as a leader in biotechnology in Europe and the world,” said AseBio’s president, Cristina Nadal.
• “Spain can position itself as a key pillar for European biotechnology investments,” stated Olivér Várhelyi, European Commissioner for Health and Animal Welfare.

AseBio

More than 60% of biotech R&D staff are women, who represent 29% of management teams

08/03/2026

Services · Talento

• Although the biotech sector is at the forefront, we still face persistent structural barriers that hinder women’s retention, promotion, and leadership in science and technology.
• Globally, fewer than 30% of researchers are women, indicating that female talent is still not fully integrated into research and innovation.
• AseBio and PBio celebrate the fourth edition of “A Day with a Woman in Biotech,” an initiative that brings students closer to the biotechnology business environment and its career opportunities while fostering entrepreneurship.

AseBio

The new European Regulation on unsold products highlights the role of biotechnology in driving the circular economy across the entire value chain

25/02/2026

Industrial biotechnology · Bioeconomy · Circular economy

• The regulation requires companies to transparently report unsold or discarded products, including quantities, causes, treatment, and prevention measures.
• For the biotechnology sector, it represents both a challenge and an opportunity, as it requires improved information management and the adoption of circular practices that promote more sustainable products.
• The Spanish Bioindustry Association underscores that biotechnology is key to reducing waste, valorising resources, and advancing towards a sustainable, innovative and circular production system, reinforcing its transformative role in the European economy.

AseBio

Childhood Cancer Needs Greater Awareness and Stable Funding to Accelerate Innovative Therapies into Clinical Practice

15/02/2026

Healthcare · Innovative drugs · Personalized medicine · Advanced therapies

• In Spain, around 1,500 cases of childhood cancer are diagnosed each year (1% of the total), making research more challenging and requiring cooperation among multiple centers, including internationally, to access sufficient samples and data.
• Advances in translational research and pediatric clinical trials are focused on developing less toxic treatments that can increase survival and minimize long-term side effects.
• Marina Salmón, Head of Project Evaluation at the Scientific Foundation of the Spanish Association Against Cancer, a partner of AseBio, analyzes the situation on International Childhood Cancer Day.

AseBio

More Women in Science: Biotechnology as a Driving Force to Close the Gender Gap

11/02/2026

Services

• Women remain underrepresented in key sectors of the Fourth Industrial Revolution, accounting for only 22% of professionals in artificial intelligence, 28% in engineering, and 40% in computer science and computing.
• In Spain, although women represent 57% of the university student population and the country ranks fourth in gender equality in Europe, their presence in STEAM degrees and in technological research areas remains low: only 13% choose these fields, they account for 42.1% of R&D personnel, and 25.5% of patent applicants. These figures show that significant gender gaps persist.
• In this context, AseBio and the Biotech Platform are launching the fourth edition of “A Day with a Biotech Woman”, enabling young women—the emerging talent of today—to experience and closely follow the work of a professional in our industry throughout an entire working day.

AseBio

Biotechnology in the fight against cancer: from smart vectors to protein disorder as a therapeutic opportunity

04/02/2026

Healthcare · Innovative drugs · Personalized medicine · Advanced therapies

• Biotechnology makes it possible to identify specific biomarkers and translate this knowledge into more effective and safer targeted therapies, improving clinical outcomes and quality of life, accelerating the integration of innovation into healthcare systems, and opening up new opportunities to treat cancer earlier and more precisely.
• Ohmline, developed by Lifesome Therapeutics, is a smart vector that enhances drug efficacy, reduces toxicity, and reaches hard-to-treat tumors, offering new options for aggressive or resistant cancers.
• Nuage Therapeutics turns protein disorder into a therapeutic opportunity by designing compounds that act on hard-to-drug proteins. Its ASCL1 and KLF5 programs aim to deliver precision therapies for aggressive cancers with limited treatment options. This technology opens a new paradigm in drug discovery.

AseBio